Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Assets (2020 - 2025)

Historic Return on Assets for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to 0.05%.

  • Mirum Pharmaceuticals' Return on Assets rose 1000.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.13% for FY2024, which is 1900.0% up from last year.
  • As of Q3 2025, Mirum Pharmaceuticals' Return on Assets stood at 0.05%, which was up 1000.0% from 0.08% recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Return on Assets ranged from a high of 0.05% in Q3 2025 and a low of 0.74% during Q3 2021
  • Its 5-year average for Return on Assets is 0.29%, with a median of 0.25% in 2022.
  • Its Return on Assets has fluctuated over the past 5 years, first soared by 6100bps in 2022, then tumbled by -2700bps in 2023.
  • Quarter analysis of 5 years shows Mirum Pharmaceuticals' Return on Assets stood at 0.32% in 2021, then decreased by -19bps to 0.38% in 2022, then surged by 33bps to 0.25% in 2023, then soared by 48bps to 0.13% in 2024, then soared by 58bps to 0.05% in 2025.
  • Its last three reported values are 0.05% in Q3 2025, 0.08% for Q2 2025, and 0.11% during Q1 2025.